Velarion Records
Free. Unsubscribe any time.

CRESCENT BIOPHARMA, INC. (CBIO)

CRESCENT BIOPHARMA, INC. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 7 transactions and 68,156 shares. None carries the SEC's AFF10B5ONE flag; all 7 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in CRESCENT BIOPHARMA, INC. 7

Adoption dates in CRESCENT BIOPHARMA, INC. 3

Results prints in CRESCENT BIOPHARMA, INC. 0

Trades before a print in CRESCENT BIOPHARMA, INC. 0

Interval to CRESCENT BIOPHARMA, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates CRESCENT BIOPHARMA, INC. states

Filing text: “10b5-1 instruction adopted by the reporting person on February 28, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.